Development of Cellular Therapeutics

Prof. Wolfgang Holter, MD
Our group focuses on the development of therapeutic strategies based on T cells modified with chimeric antigen receptors (CARs).

Clinical Cell Biology and FACS Core Unit

Assoc. Prof. René Geyeregger, PhD
With our engagement in flow cytometry and GMP-compliant work, we are a supportive interface between research and therapy.